Exact Sciences Honored by AMGA for Its Commitment to Advancing High Performance Health

Alexandria, VA – AMGA has named Exact Sciences the recipient of its 2021 Distinguished Corporate Partner Award in recognition of its ongoing support and partnership. 

Each year, AMGA presents the Distinguished Corporate Partner Award to an industry partner that supports the team model of healthcare delivery and develops programs and services to help medical groups and health systems deliver high-quality, low-cost care. As a Premier Corporate Partner, Exact Sciences has supported many AMGA initiatives, including a Quality and Innovation Collective on colorectal cancer screening, and Platinum Sponsorship for both the 2021 and 2022 Annual Conferences.

“Exact Sciences shares AMGA’s dedication to helping medical groups and health systems deliver better care to their patients,” said Jerry Penso, M.D., M.B.A., AMGA president and CEO. “Through their sustained support, AMGA has been able to expand its programs, and consequently offer its members more opportunities to advance their performance. We thank Exact Sciences for their ongoing support and look forward to their continued partnership with us.”

“We are thrilled and honored to be chosen by AMGA as the 2021 Distinguished Corporate Partner. We choose to invest in uniquely collaborative solutions that bring together the best leaders in healthcare,” said Julie Sievert, M.P.H., RD, Director, Channel Marketing at Exact Sciences. “We believe that with technology, and a common mission to better solve complex, unsolvable problems in healthcare we will, together, make a difference on perennially low cancer screening rates.   Collaborating with AMGA and its members has been a truly rewarding and inspiring way for us to focus on our company’s mission of eradicating cancer through early detection.  Thank you, AMGA, for this humbling recognition!”

###

About Exact Sciences
 A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard® and Oncotype DX®, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

About AMGA
 AMGA is a trade association leading the transformation of health care in America. Representing multispecialty medical groups and integrated systems of care, we advocate, educate, innovate, and empower our members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of our members’ recognized excellence in the delivery of coordinated, high-quality, high-value care. Over 177,000 physicians practice in our member organizations, delivering care to more than one in three Americans.